Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

CREATES Act Has a Penalty Problem

28 Mar 2019

• By Derrick Gingery

Washington DC Capitol dome detail with waving american flag

Related Content

REMS Abuse Website: Has It Changed The Behavior Of Innovators?

12 Feb 2019

CREATES Act To Face Major Reshaping By Innovator-Friendly Amendments On Senate Floor

14 Jun 2018

REMS Abuse Website: Celgene, Actelion Top List Of Suspected 'Gamers'

18 May 2018

Trump FY 2020 Budget Renews Push To Reform 180-Day Exclusivity

12 Mar 2019

CREATES Act: Republican Lawmakers Worry About Frivolous Lawsuits By Generic Firms

13 Mar 2019

Additional Topics

United States Pricing Debate Legislation Regulation FDA Generic Drugs BioPharmaceutical

More from Pricing Debate

More from Market Access

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.